控制发作与痴呆症患者的死亡率,认知和功能相关联
Ifrah Zawar1, Mark Quigg1,2, Soutik Ghosal3
1Comprehensive Epilepsy Program, Department of Neurology, University of Virginia, Charlottesville, VT.
Annals of neurology
|October 30, 2024
概括
痴呆症患者控制不良的发作显著增加死亡风险,并恶化认知和功能结果. 有效的发作管理对于改善这一群体的生活质量和生存至关重要.
科学领域:
- 神经学 神经学
- 老年病的医生 老年病的医生
- 痴呆症研究 痴呆症研究
背景情况:
- 控制发作对痴呆症患者 (PWD) 结果的影响尚不清楚.
- 痴呆症通常与发作风险增加和发作模式改变有关.
研究的目的:
- 研究控制如何影响PWD患者的死亡率,功能,认知和情绪.
- 为了比较PWD中经常性发作,远程发作和没有发作的结果.
主要方法:
- 一项纵向的多中心研究,涉及来自39个阿尔茨海默病中心的26,501名参与者.
- PWD被分为经常性,远程和没有的组.
- 韦布尔生存分析用于评估死亡风险,并根据各种临床和人口因素进行调整.
主要成果:
- 反复发作与远程和无发作相比,与明显更高的死亡风险 (aHR=1.79) 有关.
- 复发性发作 (2.4年) 与远程 (4.0年) 和没有发作 (4.7年) 的患者的中位生存时间最短.
- 经常性发作的PWD表现出较差的认知能力,日常功能和增加的身体依赖.
结论:
- 在PWD中控制不良的复发性发作与较差的死亡率,功能和认知结果有关.
- 及时识别和管理正在进行的发作对于PWD至关重要.
- 这项研究强调了在痴呆症护理中解决活动的关键需要.
相关概念视频
Dementia
97
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
97
Seizures: Classification
304
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
304
Alzheimer's Disease: Overview
449
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
449
Alzheimer's Disease: Treatment
165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165
Arteries of the Lower Limbs
178
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
178
Electroconvulsive Therapy
25
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
25


